How Complement Proteins Help Clear Pathogens

Clinical immunology scientist loading sealed serum samples into a laboratory analyzer

How Complement Proteins Help Clear Pathogens Explainer

Complement is a network of soluble and membrane-associated proteins that circulates mostly in inactive forms. It can recognize infection directly or amplify antibodies already bound to a target. Once triggered, sequential proteolytic reactions create many active fragments from a small initiating signal, so the system must be both rapid and tightly regulated.

Three major initiation routes converge. The classical pathway often begins with antibodies or related recognition molecules on a surface. The lectin pathway detects characteristic carbohydrate patterns. The alternative pathway continuously samples surfaces through low-level C3 activation and becomes amplified where protective regulators are absent. Each route forms an enzyme complex that cleaves complement component C3.

C3 cleavage produces C3a and C3b. C3b forms covalent attachments near the activation site, coating the target with an opsonin that phagocytes can recognize. Surface-bound C3b also helps build additional convertases, creating positive feedback. Further reactions split C5 and begin assembly of the terminal membrane-attack complex on susceptible membranes.

Small fragments such as C3a and C5a act as inflammatory signals. They recruit and activate immune cells, change blood-vessel behavior, and help concentrate defense near a threat. The terminal complex can form pores, especially effective against some Gram-negative bacteria. Many pathogens resist, shed, or hijack complement components, so killing is not universal.

Human cells carry regulators that dismantle convertases, inactivate deposited fragments, or block membrane-attack assembly. Soluble regulators provide another layer of protection. When these controls fail, complement can injure blood cells, kidneys, eyes, or other tissues. Conversely, missing complement components can increase susceptibility to particular infections or impair immune-complex clearance.

Clinical tests can measure total pathway function, individual proteins, activation fragments, or antibodies against complement components. Results must be interpreted with symptoms and sample handling because activation can occur after blood is drawn. Complement-targeting medicines can reduce harmful inflammation, but suppressing a defense pathway also changes infection risk and vaccination needs.

Complement circulates as inactive proteins that activate in a controlled cascade.

Classical, lectin, and alternative pathways all generate C3-cleaving enzymes.

C3b coats targets and improves recognition by phagocytic cells.

C3a and C5a recruit inflammation; terminal components can form membrane pores.

Host regulators prevent the cascade from spreading across healthy cell surfaces.

Deficiency and overactivation cause different disease and infection risks.

Explore more "Explainers"

Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.